11 December 2025

DMARDS Pharmaceuticals

DMARD routine bloods loosen

27 November 2025

Biologics Clinical research Psoriasis

Treat-to-target trumps therapy choice in PsA

27 November 2025

Biologics Psoriasis

Routine antibiotics linked to earlier biologic drop-off

30 October 2025

ACR Biologics

Proteomic analysis reveals how sex differences shape PsA

18 September 2025

Biologics Lupus

Anifrolumab moves closer to self-administration

18 September 2025

Biologics

Biologics trigger unexpected hair loss

24 July 2025

Biologics Rheumatology

Secukinumab falls short in GCA trial

10 July 2025

Biologics Cancer Rheumatoid Arthritis

ORAL Surveillance cancer signal replicated in observational data

3 April 2025

Biologics Research

Combination targeted therapies are safe – mostly

3 April 2025

Anti JAKS Sjogren Syndrom

Tofacitinib promising for Sjögren’s Disease

6 February 2025

Interstitial Lung Disease Rheumatoid Arthritis TNF

TNF inhibitors safe in RA-associated ILD

24 October 2024

Biologics Bullous Pemphigoid

‘Breakthrough’ mAb in moderate to severe bullous pemphigoid

18 July 2024

Arthritis DMARDS

Patients’ journeys with accessing biologics

6 June 2024

Corticosteroids Osteoporosis

Injected corticosteroids not linked to fracture

9 May 2024

Anti JAKS giant cell arteritis Pharmaceuticals

New option for GCA on the cards

1 March 2024

Medications PBS

It’s rheumatology’s time for 60-day prescribing